Cingulate Stock Quote CING - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Cingulate Inc (CING) Quote

Cingulate Inc (CING)

0.8801

0.0401

(4.77%)

Closed April 27 4:00PM

Delayed by 15 minutes

0.8801

0.00

(0.00%)

After Hours: 5:23PM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.8801

Bid

0.842

Ask

0.89

Volume

8,654

0.84 Day's Range 0.9299

0.75 52 Week Range 23.798

Market Cap

Previous Close

0.84

Open

0.8684

Last Trade

Last Trade Time

Financial Volume

$ 7,701

VWAP

0.889821

Average Volume (3m)

282,467

Shares Outstanding

937,000

Dividend Yield

-

PE Ratio

-0.04

Earnings Per Share (EPS)

-25.12

Revenue

-

Net Profit

-23.54M

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions cha... Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cingulate.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Cingulate Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CING. The last closing price for Cingulate was $0.84. Over the last year, Cingulate shares have traded in a share price range of $ 0.75 to $ 23.798.

Cingulate currently has 937,000 shares outstanding. The market capitalization of Cingulate is $824,560 . Cingulate has a price to earnings ratio (PE ratio) of -0.04.

Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024

KANSAS CITY, Kan., April 16, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update

$17.8 Million Raised Since Beginning of 2023$9.1 Million of Debt Converted to Equity at a PremiumPhase 3 ADHD Data Continues to Impress KANSAS CITY, Kan., April 01, 2024 (GLOBE NEWSWIRE...

Cingulate to Participate in Benzinga All Live Access Event

KANSAS CITY, Kan., March 19, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0384	4.56219555661	0.8417	0.94	0.8263	72238	0.8738487	CS
4	-0.2299	-20.7117117117	1.11	1.17	0.75	109333	0.95429815	CS
12	-1.1199	-55.995	2	2	0.75	282467	1.19186125	CS
26	-8.5199	-90.6372340426	9.4	12.7	0.75	905003	5.22127841	CS
52	-20.5199	-95.8873831776	21.4	23.798	0.75	600995	7.68396296	CS
156	-99.1199	-99.1199	100	103	0.75	414281	19.03877981	CS
260	-99.1199	-99.1199	100	103	0.75	414281	19.03877981	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M

tbonaces80

tbonaces80 1 day ago

Pending definitive agreement will be inked. $5-$10m which will cover the NDA fees of roughly $3.6m. Back that into the S/P makes it an $8 stock alone hence why HC wainwright has an estimate at $8. Couldn’t be easier

tbonaces80

tbonaces80 1 day ago

233 shareholder as of 12/2023 and 1.167M shares. This thing is a 30-50x based on NDA filing. This is a gem.

tbonaces80

tbonaces80 4 days ago

Gobble up. Buy stops sitting at $1.02.

tbonaces80

tbonaces80 5 days ago

Funding of $5-10m in deck

tbonaces80

tbonaces80 1 week ago

Loading all over here

tbonaces80

tbonaces80 2 weeks ago

Well not the sexiest news but….

tbonaces80

tbonaces80 2 weeks ago

The last flush. Expect PR tomorrow

tbonaces80

tbonaces80 3 weeks ago

Shayne says expect the update. Have your buy stops in.

tbonaces80

tbonaces80 3 weeks ago

Look at the conversion of warrants. $2 and 2.50. MM will peg higher

tbonaces80

tbonaces80 4 weeks ago

One additional strategic partnership, and this thing is a $10 stock overnight

tbonaces80

tbonaces80 1 month ago

Mispriced market. Period. Load it

tbonaces80

tbonaces80 1 month ago

I will take 10%of a $22b market especially future cash flows. The market will price that in. 3.9m/$2b. You do the math. It’s easily 200x from here

tbonaces80

tbonaces80 1 month ago

Current Status
• Ex-US
o Major UK pharma company is in final stages to execute UK agreement; $5M potential
with additional $5-10M with additional EU territories
o EU/Middle East/Latin America pharma company nearing term sheet exchange
o Brazilian pharma company nearing term sheet exchange
• US
o Commercialization agreement executed with Indegene for full service Go-To-Market
and Launch execution
o Term sheet imminent with US based company for 50/50 copromote partnership

tbonaces80

tbonaces80 1 month ago

https://www.cingulate.com/static-files/14b173b8-5a72-4927-a339-d7851ad08c3f

Link to presentation. She will Blow the roof off

tbonaces80

tbonaces80 1 month ago

Let’s see if they run it hard AH or premarket. Conference over and corporate news tomorrow 12pm Eastern

Monksdream

Monksdream 1 month ago

tbonaces80

tbonaces80 1 month ago

Private placement shares tender at $1.13. Pegged until buyer finishes. They are at the conference 18-21st. Expect partnership and fast track. Keep loading

tbonaces80

tbonaces80 2 months ago

The financials should show a book value of roughly 8-9m with 3.9m shares outstanding=$2/share. The debt was converted. So simpler

tbonaces80

tbonaces80 2 months ago

Tiny float from here. News and trial. 10x

tbonaces80

tbonaces80 2 months ago

CTX-1301 will get fast tracked. Commercial ready. This will be a monster rise. Watch the video. Look at the market in sales to less effective where those ancillary drugs effect is no where close between a drug that last 5 hours vs CING 16 hour effect. P value less than 0.001. Amazing. Concerta through Qelbree don’t compare. $22B market. Buy it.

tbonaces80

tbonaces80 2 months ago

tbonaces80

tbonaces80 2 months ago

Well. Hmm. Guess what’s up AH. Load it

tbonaces80

tbonaces80 2 months ago

Reversal in play

tbonaces80

tbonaces80 2 months ago

Well. If a stock couldn’t be more oversold then I don’t know what to say. This is a coiled spring. Trial of FDA fast track and we are 12x in a day. Micro float easy peasy. Use this low price to average in

tbonaces80

tbonaces80 2 months ago

Expect update on trials

tbonaces80

tbonaces80 2 months ago

Regained compliance!!!!

tbonaces80

tbonaces80 2 months ago

Going up today. Expect update on board and listing

Monksdream

Monksdream 2 months ago

CING new 52 week low

Legster1969

Legster1969 3 months ago

Monksdream

Monksdream 3 months ago

CING new 52 week low

🌈 1 🍆 1 👎️ 1 🤡 1 🩳 1

tbonaces80

tbonaces80 3 months ago

I’m sure that stopped out 90%

tbonaces80

tbonaces80 3 months ago

News expected. Wouldn’t short this with a borrow rate of 292%. Joking me

tbonaces80

tbonaces80 3 months ago

Short ratio is now at over 63% of the 1.75m. News is coming and will be a squeeze of 500-700%. Expected price on news $21.75. Beyond oversold. The value of pipeline alone is double this price at a minimum

tbonaces80

tbonaces80 3 months ago

raghuram says going much higher. Holdem tight

tbonaces80

tbonaces80 3 months ago

Break out of &4.67

tbonaces80

tbonaces80 3 months ago

Next stop $5.20

ckmseven788

ckmseven788 3 months ago

Agreed. Been loading and holding

tbonaces80

tbonaces80 3 months ago

tbonaces80

tbonaces80 3 months ago

This will be the coiled spring of the year. The short ratio on this is amazing. Assume 2m shares outstanding. Our team owns and has locked in a boatload. The cover will be amazingly high. FDA announces and this will open at $20-$30

tbonaces80

tbonaces80 3 months ago

Walking down on puddly volume. We are at $4.50 for another 30k shares. Oversold big time.

tbonaces80

tbonaces80 3 months ago

Our desk has 3/4 float. Just the lead underwriter Wright will lead the offer. Patience friends and hold them till a breakout of the daily.

tbonaces80

tbonaces80 3 months ago

That’s peanuts. So they have 1.7m shares. New gonna roll. S-1 will be between $5.6-8. East triple from here

ckmseven788

ckmseven788 3 months ago

That explains the 500,000 that was just added to the O/S

Golden Cross

Golden Cross 3 months ago

Pending S-1... no price yet but it is coming... about 2 months cash left... Good looking short play

tbonaces80

tbonaces80 4 months ago

Rumblings of tender offer on deck-time will tell.

da_stock_analyst

da_stock_analyst 4 months ago

#CING 🔥 watch tomorrow and this week! $CING

tbonaces80

tbonaces80 4 months ago

Nice reversal. Loaded in high $5

tbonaces80

tbonaces80 4 months ago

Analyst upgrade $3.5 to $8. She will rip

tbonaces80

tbonaces80 4 months ago

So thin. Accumulating indeed. Patience

BurgerKing82

BurgerKing82 4 months ago

No one is buying today.... Consolidating for a few days I guess

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions